Illumina showcases multi-omics potential to advance precision medicine in India

The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru

Yashoda Medicity unveils specialised thalassemia care centre in Uttar Pradesh

The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services

Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics

The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy

CARE Hospitals performs rare organ-preserving pancreatic surgery

Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes

Experts call for easing access to 2mg and 4mg nicotine replacement therapies

With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical

ADMA Biologics wins FDA nod to expand ASCENIV use in young children

GRIN Therapeutics launches Phase 3 beeline study in Europe for radiprodil in GRIN-NDD

This is an exciting and meaningful milestone for GRIN Therapeutics

Novo Nordisk posts strong Q1 as Wegovy drives global GLP-1 momentum

The standout story remains Wegovy, particularly its new oral formulation

Lilly’s Omvoh shows rare long-term remission milestone in ulcerative colitis

Eli Lilly unveils $4.5 bn Indiana expansion

The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies